白云山(00874.HK)子公司星群药业获得药品GMP证书
格隆汇9月17日丨白云山(00874.HK)发布公告,公司获悉,公司控股子公司广州白云山星群(药业)股份有限公司于近日收到广东省药品监督管理局颁发的《药品GMP证书》。
星群药业本次《药品GMP证书》认证生产线2条,为精制红花油生产线及水杨酸乙酯生产线,认证累计投入费用约人民币105万元(未经审计)。
本次星群药业中药前处理及提取车间(口服制剂、外用制剂)GMP认证所涉及的生产线,目前用于生产精制红花油和水杨酸乙酯,两者分别属于没有单独国家药品标准的中药提取物和原料,按照国家相关规定,精制红花油和水杨酸乙酯用于星群药业制剂产品心脑清软胶囊和搽剂瑞草油的生产,不单独对外销售。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.